All In Biotech

Drug Trial Radar · NCT05872620

A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)

Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,613 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,613

Actual

Start

Jun 5, 2023

Primary completion

Aug 8, 2025

Study completion Aug 8, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 visits.

Conditions

  • Obesity
  • Overweight
  • Type 2 Diabetes

Interventions

  • OrforglipronDrug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Body WeightTime frame: Baseline, Week 72

Locations

136 sites in 11 countries. Site status is shown where the registry gives one.

  • Cahaba Research - Pelham

    Pelham, Alabama

  • Novak Clinical Research - Tucson - North La Cholla Boulevard

    Tucson, Arizona

  • Yuma Clinical Trials

    Yuma, Arizona

  • AMCR Institute

    Escondido, California

  • Velocity Clinical Research, Huntington Park

    Huntington Park, California

  • Velocity Clinical Research, Westlake

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Encore Medical Research

    Hollywood, Florida

  • East Coast Institute for Research, LLC

    Jacksonville, Florida

  • South Florida Clinical Research Institute

    Margate, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • Balanced Life Health Care Solutions/SKYCRNG

    Lawrenceville, Georgia

  • Endocrine Research Solutions, Inc.

    Roswell, Georgia

  • North Georgia Clinical Research

    Woodstock, Georgia

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii

  • Solaris Clinical Research

    Meridian, Idaho

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • MedStar Good Samaritan Hospital

    Baltimore, Maryland

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • IMA Clinical Research

    Albuquerque, New Mexico

  • Albany Medical College, Division of Community Endocrinology

    Albany, New York

  • Albany Stratton VA Medical Center

    Albany, New York

  • NYC Research INC

    Long Island City, New York

  • Accellacare - Raleigh

    Raleigh, North Carolina

  • Summit Headlands

    Portland, Oregon

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • Soma Clinical Trials

    Denison, Texas

  • Epic Medical Research - DeSoto

    DeSoto, Texas

  • Biopharma Informatic, LLC

    Houston, Texas

  • Diabetes and Glandular Disease Center

    San Antonio, Texas

  • VIP Trials

    San Antonio, Texas

  • Charlottesville Medical Research

    Charlottesville, Virginia

  • Universal Research Group

    Tacoma, Washington

  • CONEXA Investigacion Clinica S.A.

    Buenos Aires, Argentina

  • Centro Diabetológico Dr. Waitman

    Córdoba, Argentina

  • Clínica Universitaria Reina Fabiola

    Córdoba, Argentina

Showing 40 of 136 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.